Not available
Quote | Medmira Inc (OTCMKTS:MMIRF)
Last: | $0.06 |
---|---|
Change Percent: | 0.0% |
Open: | $0.06 |
Close: | $0.06 |
High: | $0.06 |
Low: | $0.06 |
Volume: | 6,000 |
Last Trade Date Time: | 04/16/2024 03:00:00 am |
News | Medmira Inc (OTCMKTS:MMIRF)
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal ® G4 Rapid HIV...
HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number 11,353,450) received in 2022. Through this...
Message Board Posts | Medmira Inc (OTCMKTS:MMIRF)
Subject | By | Source | When |
---|---|---|---|
$mmirf $0.2 ? 0.0 (0.00%) | Taurus69 | investorshub | 03/22/2021 1:09:58 AM |
Time to load up with these shares, stock | Paraceratherium | investorshub | 03/01/2021 10:38:08 PM |
$mmirf $0.23469 ^ 0.00969 (4.31%) | Taurus69 | investorshub | 02/22/2021 12:40:09 AM |
$mmirf $0.25234 ? 0.0 (0.00%) | Taurus69 | investorshub | 02/03/2021 4:01:27 AM |
The dip is in from .52 good entry | Paraceratherium | investorshub | 01/24/2021 7:47:25 PM |
News, Short Squeeze, Breakout and More Instantly...
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024. Corporate update During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal ® G4 Rapid HIV...
HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number 11,353,450) received in 2022. Through this...
Correction: Extended clarification. HALIFAX, NS / ACCESSWIRE / February 1, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) is pleased to provide an update on the ongoing review process by Health Canada. The Company made the submission and since then has been working with the regulator on the...